Immunovant (IMVT) Property, Plant & Equipment (Net) (2019 - 2026)

Immunovant (IMVT) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 64,489.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 116.30 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 8,690.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.61 Bn
9 Abivax 91.71 Bn 91.71 Bn - 2.09 Mn
10 Immunovant 5.71 Bn 5.71 Bn - 443,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 443,000.00
Mar 31, 2026 443,000.00
Dec 31, 2025 531,000.00
Dec 31, 2025 531,000.00
Sep 30, 2025 632,000.00
Sep 30, 2025 632,000.00
Jun 30, 2025 737,000.00
Jun 30, 2025 737,000.00
Mar 31, 2025 844,000.00
Mar 31, 2025 844,000.00
Dec 31, 2024 752,000.00
Dec 31, 2024 752,000.00
Sep 30, 2024 671,000.00
Sep 30, 2024 671,000.00
Jun 30, 2024 565,000.00
Jun 30, 2024 565,000.00
Mar 31, 2024 462,000.00
Mar 31, 2024 462,000.00
Dec 31, 2023 376,000.00
Dec 31, 2023 376,000.00